Investor Presentation
Company Overview
SaaS Business Model Designed For Rapid Uptake
Our business model is designed for rapid penetration of the lung diagnostics market, with no upfront costs
borne by hospitals for installation and a 'pay as you go model' which avoids the capital budgets of the
hospital system.
Remote deployment allows for exponential roll out
•
•
•
4DMedical's products leverage the existing imaging software systems present in US hospitals
Hospitals are brought online to the XV platform remotely - through 3rd party supplier, ability to deploy
software in 6 days
The XV platform is expected to be compatible with majority of X-ray machines within 12 months
No upfront costs borne by hospitals for installation
.
•
•
•
Initial software configuration is paid by 4DMedical to the software provider for each new hospital
Payback period expected to be approximately 50 days on initial hospitals, with volume discounts being
negotiated with the software provider expected to rapidly reduce this towards 10 days as rollout
increases
No capital expenditure required by hospitals removes potential hurdles and delays caused by VACS
(budget approval committees), and provides a clear step change in lung diagnostic capabilities in a cost-
effective manner with no lock-ins
'Pay per use' model, with no minimum volume required and scan cost strategically priced to be less than
a CT scan (US$175 per XV LVAS test)
Immediate deployment of additional products
•
Once installed within the hospital, ability to deploy new product offering and functionality by leveraging
the XV Technology platform
Ability to scale rapidly
.
Use of third-party cloud providers and automated processing of scans allows for the rapid scale up with
minimal additional expenditure
O
SaaS
Pg 16 | Investor presentation
4DMedical™
FORMERLY 4DView entire presentation